▶주메뉴 바로가기
▶본문 바로가기
Prosecutors raided South Korea’s main stock exchange on March 15 as part of a probe into alleged accounting fraud by Samsung BioLogics. Investigators from the Seoul Central District Prosecutors’ ...
South Korean internet giant Naver said on March 15 that it has established a joint venture with Daewoong Pharmaceutical to provide medical data analysis services based on its artificial intellige...
Daewoong Pharmaceutical announced on March 14 that it is negotiating with Vietnam’s second-biggest drug maker Traphaco to expand its presence in the country. The South Korean firm acquired a 15 per...
SillaJen has delayed its board meeting, which was expected to confirm its decision for securing new funds worth around 220 billion won ($194.89 million), according to industry sources on March 14. ...
South Korea’s biotherapeutics company SillaJen ’s stock price fluctuated after a local news outlet reported that the future of its drug candidate Pexa-Vec was murky. Pexa-Vec, which is undergoing ...
South Korean new drug developer GemVax & KAEL announced on March 13 that it has recruited 90 patients to conduct phase 2 clinical trials of its treatment for Alzheimer’s disease. “Since the trials...
LG Chem, South Korea’s top chemical firm, said on March 11 it has received a $33.4 million grant from the Bill & Melinda Gates Foundation to develop a new combination vaccine. The grant will be u...
Celltrion Healthcare announced on March 11 that it won bids to supply Remsima and Truxima to two Southeast Asian countries at the end of last year. For this year, the company will be exclusively sup...
Stonebridge Ventures, spun-off from Korean private equity firm Stonebridge Capital, will invest more in the bio industry this year, according to industry sources on March 8. “Recently, we saw growin...
Korean biopharmaceutical firm Samsung Bioepis will spend 180.4 billion won (US$159.70) to build a new research and development center, its parent company said Thursday. The investment cost accoun...
Daewoong Pharmaceutical announced on March 6 that it posted sales of 1.31 trillion won (US$ 1.16 billion) last year. It has became one of the few Korean pharma firms to reach the milestone. Three ot...
SillaJen aims to secure around 220 billion won (US$194.89 million) fresh funds through issuing convertible bonds, according to industry sources on March 7. It has picked Kium Securities to organize ...
Stock exchange operator Korea Exchange has blocked condom maker Bio Genetics from getting representation on Kyung Nam Pharm’s board, according to industry sources on Mar. 6. Bio Genetics, which boug...
Korean biopharmaceutical firm Samsung Bioepis said on March 5 it has won approval from European authorities for the sale of mass dosages of its biosimilar drug Ontruzant. The European Medicines A...
Hypertension drugs gained unwanted attention in South Korea last year: More than 170 generic drugs sold by 76 local drugmakers were recalled by the Drug Ministry for their inclusion of valsartan, a c...
Rents, commissions lowered as virus rages through economy
Hanjin Group to sell hotel assets for financial health
Mobility startups immune to coronavirus outbreak
Baedal Minjok to financially support riders during coronavirus emergency
Amorepacific to sell Gangnam building for W160b
Delta hikes stake in Hanjin KAL in support of chairman
JR AMC gets green light for Korea’s 1st cross-border REIT listing
Meet the ‘3 Bs’ behind South Korea’s soft power
February 27, 2020
